KBF Victoria Fund – Research on Epilepsy and Autism

Closing Date: 31/01/2023

Funding is available for research institutions in Europe (including Israel) to study the relationship between epilepsy and autism.

The King Baudouin Foundation (KBF/KBS – Koning Boudewijnstichting/FRB – Fondation Roi Baudouin) is a Belgian independent, pluralistic foundation established in 1976, working in Belgium and at the European and international level. It seeks to change society for the better and invests in inspiring projects and individuals. The Fund Victoria is managed by the KBF with the help of an international scientific jury and a steering committee.

Through the Fund, KBF aims to develop research into the relationship between epilepsy and autism. It is common for autism and epilepsy to co-occur, but the shared causal mechanisms and their temporal relationship is not understood, hampering effective treatment strategies and interventions. In order to address this, the Fund Victoria focuses on producing innovative research on the shared pathophysiological mechanisms underlying both epilepsy and autism which, if scientifically successful, will create novel treatment targets for these neurodevelopmental disorders.

KBF is particularly interested in multidisciplinary, multicentric projects with translational potential.

Funding body King Baudouin Foundation (KBF/KBS – Koning Boudewijnstichting/FRB – Fondation Roi Baudouin)
Maximum value €1,000,000
Reference ID S24347
Category Medical Research
Fund or call Fund